Kathleen Borthwick serves as Executive at Passage BIO, Inc., where they oversee executive responsibilities. Since joining the company, Kathleen Borthwick has executed 8 insider transactions totaling $49.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 8, 2026 involved exercising options for 5,000 shares valued at $0.
Kathleen Borthwick currently holds 5,000 shares of Passage BIO, Inc. (PASG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen Borthwick has been a net seller of PASG stock. They have purchased $0 and sold $49.2K worth of shares.
Kathleen Borthwick's most recent insider trade was on Jan 8, 2026, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $18.44 |
| Discretionary |
| Jan 8, 2026 | PASG | $0 | Option Exercise | 5,000 | $N/A | Discretionary |
| Jan 15, 2025 | PASG | $0 | Award | 10,000 | $N/A | Discretionary |
| Feb 13, 2024 | PASG | $1.4K | Sale | 1,470 | $0.97 | Discretionary |
| Feb 10, 2024 | PASG | $0 | Option Exercise | 4,000 | $N/A | Discretionary |
| Jan 2, 2024 | PASG | $9.7K | Sale | 10,672 | $0.91 | Discretionary |
| Dec 31, 2023 | PASG | $0 | Option Exercise | 30,000 | $N/A | Discretionary |